Skip to content

argenx SE

US · ARGX #369 by market cap Listed 2017
925.70 -16.34 -1.73%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About argenx SE

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Founded
2008
CEO
Mr. Tim Van Hauwermeiren, M. Sc.
Employees
3,522
Headquarters
Amsterdam, Noord-Holland, Netherlands (the)
Fiscal year end
12-31
Website
argenx.com

Company profile

Exchange
US
Symbol
ARGX
Market-cap rank
#369
Listing date
2017-05-18
Market cap
58.21B
Float cap
58.12B
Shares out
62.89M
Float shares
62.78M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

argenx SE discussion 0 comments

Add a comment